Compare Cassava Sciences Inc (FLNA) vs STMicroelectronics NV (STM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs STMicroelectronics NV — how do they compare? Cassava Sciences Inc trades at $1.08 (market cap $53.14M), while STMicroelectronics NV trades at $62.44 (market cap $59.83B). The key difference: STMicroelectronics NV is far larger — about 1125.9× Cassava Sciences Inc's market cap, and STMicroelectronics NV pays a 0.53% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | STM | |
|---|---|---|
Market Cap | $53.14M | $59.83B |
Sector | Health | Financials |
52-Week High | $4.64 | $79.91 |
52-Week Low | $1.09 | $21.20 |
Enterprise Value | -$33.43M | $58.04B |
Dividend Yield | — | 0.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
STM (STMicroelectronics) trades at $63.00, down 10.17% in the past 24 hours, reflecting bearish technical momentum. The stock shows mixed fundamentals with a high P/E ratio of 423.44 and thin net income margin of 1.19%, though recent Q3 2025 earnings beat expectations. Analyst consensus remains positive with a $72.33 price target, supported by AI and automotive chip partnerships highlighted in recent news (Zacks Investment Research, July 14, 2026). Cash flow improved to $555 million in 2025, but revenue has declined from 2023 peaks.
Outlook: STM faces near-term pressure from earnings misses and high valuation, but long-term growth drivers in AI and automotive sectors offer potential upside. Key risks include competitive pressures and reliance on semiconductor cycle recovery. Institutional sentiment is cautiously optimistic with 52% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About STMicroelectronics NV
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.
Read more on STM →
